OptimizeRx Corporation (OPRX) Stock buybacks 2017–2024
OptimizeRx Corporation (OPRX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$7.5MFY2024 · since FY2017: $806,915 → $7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $7.5M | -62.4% |
| FY2023 | $20.0M | — |
| FY2018 | $390,000 | -51.7% |
| FY2017 | $806,915 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OPRX financial trends
OPRX RevenueOPRX Net incomeOPRX Net marginOPRX Gross profitOPRX Gross marginOPRX Operating incomeOPRX Operating marginOPRX Operating cash flowOPRX Free cash flowOPRX Capital expendituresOPRX Return on equityOPRX Dividends paidOPRX Total assetsOPRX Total liabilitiesOPRX Shareholders’ equityOPRX overview →